Abanilla, Baby Girl .

HRN: 26-58-71  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/23/2025
AMPICILLIN 250MG (VIAL)
03/23/2025
03/30/2025
IV
190mg
Q12
Potentially Septic Newborn
Waiting Final Action 
03/23/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/23/2025
03/30/2025
IV
57mg
OD
PNSB
Waiting Final Action 
03/25/2025
CEFOTAXIME 500MG (VIAL)
03/25/2025
03/31/2025
IV
200 Mg
Q12H
Neonatal Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: